ATTORNEYS FOR GYNECARE MORCELLATOR LAWSUITS

We are investigating cases involving women who have suffered severe complications as a result of the Gynecare Morcellex Tissue Morcellator, the Morcellex Sigma Tissue Morcellator System, and the Gynecare X-Tract Tissue Morcellator, all sold by Johnson & Johnson’s Ethicon division. We are taking cases on behalf of women who have had their cancer spread after these products were used during a hysterectomy or myomectomy in women with uterine fibroids. Unlike many other law firms claiming an expertise in this field, who are “collecting” cases, we are actually filing lawsuits and aggressively litigating cases involving other products designed and sold by Johnson & Johnson, Ethicon & Gynecare for our clients.

Because we have chosen to pursue only Ethicon and Johnson & Johnson, we are able to focus our resources and expertise on a narrow target, which we believe maximizes our ability to successfully litigate these cases. In fact, one of our attorneys has been appointed Co-Liaison Counsel by the Court to lead actions against Ethicon and Johnson & Johnson involving their vaginal mesh products. If you believe that you or a loved one has had their cancer spread during one of these procedures, and you are interested in learning more about how we can help, please contact a Gynecare and Ethicon Power Morcellator Lawyer today for a free consultation.

What is a Laparoscopic Power Morcellator?

The Gynecare Morcellex Tissue Morcellator, the Morcellex Sigma Tissue Morcellator System, and the Gynecare X-Tract Tissue Morcellator are medical devices used during different types of minimally invasive surgeries. These can include certain procedures to treat uterine fibroids, such as removing the uterus (hysterectomy) or removing the uterine fibroids (myomectomy). Morcellation refers to the division of tissue into smaller pieces or fragments and is often used during laparoscopic surgeries to facilitate the removal of tissue through small incision sites.

Investigation into Ethicon Morcellator Products

Our investigation has confirmed that the Gynecare Morcellex products may not have met reasonable safety standards. On April 17, 2014, the FDA issued Safety Communication concerning the use of Laparoscopic power morcellators are medical devices used during different types of laparoscopic (minimally invasive) surgeries. The FDA determined that because 1 in 350 women undergoing surgery for uterine fibroids has an unsuspected uterine sarcoma, and the use of products like the Gynecare Morcellex Tissue Morcellator, the Morcellex Sigma Tissue Morcellator System, and the Gynecare X-Tract Tissue Morcellator spread the cancerous tissue within the abdomen and pelvis, such power morcellators should not be used.

On April 29, 2014, Ethicon and Johnson & Johnson announced that they were suspending worldwide sales of their laparoscopic power morcellators after a warning by the US Food and Drug Administration (FDA) that the devices may spread occult cancer in the course of fibroid removal. J&J notified its power morcellator customers about the sales suspension yesterday. Despite the sales suspension, Ethicon has not issued a recall of the Gynecare Morcellex Tissue Morcellator, the Morcellex Sigma Tissue Morcellator System, or the Gynecare X-Tract Tissue Morcellator.

In our view, Ethicon and Johnson & Johnson did not adequately disclose and warn of the significant risks of these products. These inadequacies deprived surgeons and women of the opportunity to make informed choices as to how they wanted their treatable medical conditions to be repaired – and leading them to choose to permit the use of Laparoscopic power morcellators during their surgery – sometimes with catastrophic results.

Gynecare Morcellex Morcellator Cancer Lawyers

Uterine fibroids are noncancerous growths that develop from the muscular tissue of the uterus. Most women will develop uterine fibroids (also called leiomyomas) at some point in their lives, although most cause no symptoms. In some cases, however, fibroids can cause symptoms, including heavy or prolonged menstrual bleeding, pelvic pressure or pain, and/or frequent urination, requiring medical or surgical therapy.

Many women choose to undergo laparoscopic hysterectomy or myomectomy because these procedures are associated with benefits such as a shorter post-operative recovery time, a reduced risk of infection compared to abdominal hysterectomy and myomectomy, and significantly less scarring. Many of these laparoscopic procedures are performed using a power morcellator. If laparoscopic power morcellation is performed in women with unknown uterine sarcoma, there is a risk that the use of this device will spread the cancerous tissue within the abdomen and pelvis, significantly worsening the patient’s likelihood of long-term survival.

Power Morcellator Complication Law Firm

With a lawsuit against Gynecare, Ethicon and Johnson & Johnson, we may be able to help you obtain compensation for your pain and suffering and other damages. To learn more about a potential Gynecare Morcellator lawsuit, you should contact us immediately as the statutes of limitations restrict the time frame in which you may be able to pursue your claims. If you believe that you or a loved one has had their cancer spread during one of these procedures, and you are interested in learning more about how we can help, please contact a Gynecare and Ethicon Morcellator Lawyer today for a free consultation.

Disclaimer: Transmission and receipt of information contained on this web site does not create an attorney-client relationship between the user and Mr. Mendelsohn or our law firm. Only an express written agreement between the user and our law firm can create an attorney-client relationship with our law firm. This web site constitutes an ADVERTISEMENT. Before making your choice of attorney, you should give this matter careful thought. The selection of an attorney is an important decision. If you believe this web site is inaccurate or misleading, you may report same to the committee on Attorney Advertising, Hughes Justice complex, CN 037, Trenton, New Jersey 08625.